Tuesday, May 06, 2025 9:16:12 AM
This Noname Guy/Girl, Galzus Research, has written a bash post against NWBO & he has been on their MB 24/7 trying to convince investors that he knows what he is talking about.... hummmmm.. ????
And he has been repeatedly posting Supportive sStatement on behalf of NVCR...
HAS HE BEEN PAID BY NVCR FOR HIS noName ANTI-NWBO PUBLICATION??
HE actions seems to support that view?? ....
Below is he just posted there
---------------------------------------------
Galzus Research
Re: improving post# 766066
Tuesday, May 06, 2025 8:55:56 AM
Post#
766069
of 766069
A real-world study shows that 5-year OS with tumor-treating fields is around 17%. Do you feel similarly enthusiastic about TTF here?
And he has been repeatedly posting Supportive sStatement on behalf of NVCR...
HAS HE BEEN PAID BY NVCR FOR HIS noName ANTI-NWBO PUBLICATION??
HE actions seems to support that view?? ....
Below is he just posted there
---------------------------------------------
Galzus Research
Re: improving post# 766066
Tuesday, May 06, 2025 8:55:56 AM
Post#
766069
of 766069
A real-world study shows that 5-year OS with tumor-treating fields is around 17%. Do you feel similarly enthusiastic about TTF here?
Recent NVCR News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/21/2026 08:00:26 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/08/2026 09:01:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 11:01:40 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 11:01:01 AM
- Novocure Reports First Quarter 2026 Financial Results • Business Wire • 04/30/2026 11:00:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/24/2026 08:08:39 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/20/2026 08:06:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/20/2026 08:05:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 09:04:13 PM
- Novocure to Report First Quarter 2026 Financial Results • Business Wire • 04/01/2026 11:00:00 AM
- Novocure shares gain on encouraging pancreatic cancer trial results • IH Market News • 03/26/2026 02:24:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 11:00:57 AM
- Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer • Business Wire • 03/26/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:33:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:32:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:32:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 09:06:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:54:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:53:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:42:44 PM
